Polymyxin B is an N-terminally fatty acylated peptide antibiotic isolated from Bacillus polymyxa. 1, 2) Polymyxin B contains six a,g-diaminobutyric acid (Dab) residues. The gamino group of Dab 4 is acylated by C-terminal Thr 10 to form a 23-member lactam ring 3, 4) resulting in a peptide that has antimicrobial activity against Gram-negative bacteria. The mechanism of action of Polymyxin B is believed to be due to the amphiphilic character of the molecule, with the basic Dab side chains interacting with the negative charges of the lipid A portion of lipopolysaccharides (LPS) on the cell surface of bacteria, and the hydrophobic D-Phe-Leu in the lactam ring and the fatty acyl group at the N-terminus interacting with the lipophilic part of LPS. 5, 6) These interactions lead to disordering of Gram-negative bacterial cell membranes, resulting in cell death. 7) Since the total solid phase synthesis of polymyxin B 1 was first reported by Sharma in 1999, 8) various polymyxin B analogs have been synthesized and evaluated for biological activity. [9] [10] [11] [12] [13] [14] [15] [16] [17] However, the structure-activity relationship of polymyxin B peptides is not understood in detail, due to the lack of extensive works employing highly pure peptides. We previously reported a study aimed at clarifying the contribution of the N-terminal fatty acyl groups of various polymyxin B family peptides to biological activity, as well as the development of N-terminal analogs without fatty acyl groups. 16, 18, 19) The aim of the present study was to clarify the structural requirements of the side chain of each amino acid residue by means of alanine scanning, and to further examine the role of the hydrophobic portion (D-Phe-Leu) of the polymyxin B 3 lactam ring in antimicrobial activity and LPS binding, employing sixteen synthetic peptides (Fig. 1 ).
Experimental
General HPLC was performed using two 510 pumps (Waters Corp., Milford, MA, U.S.A.), a U6K injector (Waters), an S310 model II UV detector (Soma Optics Ltd., Tokyo, Japan), a 680 Automated Gradient Controller (Waters), and a chromatocorder 21 (System Instruments Co., Ltd., Tokyo, Japan). Gel column chromatography was carried out using Toyopearl HW-40-S (Tosoh Corporation, Tokyo, Japan). Fast-atom bombardment mass spectra (FAB-MS) were obtained on a JMS-DX300 mass spectrometer (JEOL Ltd., Tokyo, Japan). Amino acid analysis of peptide acid hydrolysates was conducted on a model 7300 amino acid analyzer (Beckman Instruments Ltd., Fullerton, CA, U.S.A.). The optical rotations of the peptides were measured with a DIP-370 digital polarimeter (Nippon Bunko Co., Ltd., Tokyo, Japan). Deprotection reaction of protected peptides with anhydrous HF was carried out in a Teflon HF apparatus (Peptide Institute Inc., Osaka, Japan). HP-TLC was performed on precoated silica gel plates (Kieselgel 60; Merck, Darmstadt, Germany). All reagents, solvent used for peptide synthesis and Fmoc-amino acids were obtained from Watanabe Chem. Ind. Ltd., Hiroshima, Japan. ]-polymyxin B 3 (3, Fig. 2 ). The synthetic strategy was essentially as reported previously. 16) In brief, the protected peptide was constructed on 4-hydroxylmethylphenoxymethyl-resin (HMP-resin or Wang-resin, 0.74 mmol/g, Novabiochemläufelfingen, Switzerland) by a solid phase methodology using an ABI 433A peptide synthesizer (Applied Biosystems, Foster City, CA, U.S.A.). Protected amino acids used were Fmoc-Dab 
Synthesis of
The excess TFA was evaporated in vacuo and the residue was lyophilized from dioxane. The products were dissolved in dimethylsulfoxide (DMSO) (2 ml) and fractionated on a column (1.6ϫ95 cm) of Toyopearl HW-40-S using DMF : H 2 O (9 : 1) as eluent. Fractions containing the main product (3 L ) were combined, evaporated, and the partially purified product (the purity: 82% by HPLC analysis measured at 210 nm) was lyophilized from dioxane. ]-polymyxin B 3 (3) was purified by HPLC on a CAPCELL PAK C 18 UG-80 5 m (2ϫ15 cm) column using acetonitrile-0.1% TFA as eluent. The main peak was collected and the combined eluents were evaporated and lyophilized. The product was chromatographed on a Toyopearl HW-40-S column (1.5ϫ57 cm) using 25% CH 3 CN in 5 mmol/l HCl as eluent. Purified product 3 was obtained by lyophilization as a hydrochloride salt; yield 29 mg (44.4%). The other polymyxin B 3 analogs, 1, 2 and 4-16, were prepared in the same manner except for the L-Trp or D-Trp-containing peptides (14, 15), which were obtained by treating 14 C and 15 C with HF (2 ml) containing anisole (0.2 ml) and ethanedithiol (0.2 ml). For amino acid analysis of synthetic peptides, acid hydrolysis was carried out with vapor of 6 mol/l HCl containing 3% phenol at 130°C for 3 h. The peak of Dab on the analysis was determined as Lys. Data of amino acid analysis are shown in Table 1 . Characterization and analytical data of synthetic peptides 1-16 are shown in Table 2 .
Bacteria and Susceptibility Test Escherichia coli (E. coli) IFO 12734, Salmonella Typhimurium (S. Typhimurium) IFO 12529 and Pseudomonas aeruginosa (P. aeruginosa) IFO 3080 were purchased from the Institute for Fermentation, Osaka (IFO), Japan. These bacterial strains were grown overnight at 37°C on nutrient agar medium and harvested in sterile saline. The densities of the bacterial suspensions were determined at 600 nm, using a standard curve relating absorbance to the number of colony forming units (CFU).
Antibacterial activity of the synthetic peptides was evaluated by comparison with commercially available polymyxin B (Sigma Chemical Co., St. Louis, MO, U.S.A.). Minimum inhibitory concentrations (MIC) of the synthetic peptides against the bacterial strains were determined using a standard microplate dilution method (nϭ6-8). One hundred microliters of each serially diluted peptide in distilled water (0.25-512 nmol/ml) was added to a mixture of 10 ml bacterial suspension (approximately 10 6 CFU/ml) and 90 ml Inc., Corning, NY, U.S.A.). The plates were then incubated overnight at 37°C for MIC evaluation. The MIC value was expressed as the lowest final concentration (nmol/ml) at which no growth was observed (Table 3) . LPS Binding Assay of Synthetic Peptides to LPS Following a method described previously, 16) A solution of each polymyxin B 3 analog (1 mmol/ml) (4 ml each) was added cumulatively to the quart cuvette at 5-min intervals to obtain eight data points (4-32 nmol). The change in fluorescence intensity was measured after each addition with a fluorescence spectrophotometer (F-850, Hitachi Instrument Co., Tokyo, Japan) using an excitation wavelength of 330 nm and an emission wavelength of 490 nm. The initial intensity of fluorescence was taken as 100%. The percent fluorescence intensity was plotted as a function of peptide concentration. The binding experiments were repeated at least three times for each peptide to test the reproducibility of the results. The concentrations required for 50% quenching of [Dab(N g -dansylGly) 1 ]-polymyxin B 3 bound to LPS (IC 50 ) were derived from the quenching curves of the synthetic peptides (Figs. 4, 5, Table 3 ).
Results and Discussion
Synthesis The synthesis of polymyxin B 3 analogs (1-16) shown in Fig. 1 was carried out as reported previously. 16) The peptide chain was constructed by solid-phase synthesis using Fmoc-amino acids bearing benzyl-type protecting groups on the side chain functional groups, except for the Dab at position 4, whose g-amino function was protected by Boc. After the cleavage of the solid support and the Boc protecting group on Dab 4 with TFA, the linear partially protected peptides (1 L -16 L ) were cyclized between the a-COOH of Thr(Bzl) 10 and the g-NH 2 of Dab 4 using DPPA 20) at 4°C in minimal amounts of DMSO-DMF (1 : 1). The cyclization reaction proceeded quantitatively in a high concentration (ca. 0.01 mmol/ml) solution of 1 L -16 L to yield 1 C -16 C , which were treated with HF to yield polymyxin B analogs (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . The purity of the synthetic peptides was Ͼ97% as shown representatively in Fig. 3 for analog 3 . The results demonstrated the usefulness of the synthetic protocols described herein. However, during the present Ala-scanning study, it was noted that no cyclization product was obtained from octanoyl-Dab(2-ClZ)
-OH (7Ј L ), which was prepared as an intermediate for the synthesis of [Ala 8 ]-polymyxin B 3 (7Ј). No considerable decease of the starting material (7Ј L ) was proved by HPLC analysis of the reaction mixture in the presence of a large excess of DPPA for 48 h. When HATU was used as a cyclization reagent, the decrease of 7Ј L peak was observed without the appearance of desired product peak (data not shown), suggesting that polymer formation occurred under the reaction condition. Then an N gacetylated peptide at Dab 8 residue (7) was designed to evaluate the biological role of the side chain. When Dab(Ac) was introduced at position 8, the intra-molecular reaction of 7 L proceeded smoothly to give a lactam 7 C . It can therefore be assumed that Ala 8 -analog (7Ј L ) has an exceptionally special conformation under the reaction condition, by which the lactam formation is completely disturbed.
Antimicrobial Activity The antimicrobial activity of the synthetic peptides (1-16) was estimated by the standard micro plate dilution method. The minimum inhibitory concentration (MIC) values of peptides toward three Gram-negative bacteria, E. coli, S. Typhimurium, and P. aeruginosa, are summarized in Table 3 . Polymyxin B (Sigma Co.) was used as a standard for antimicrobial potency. (14) showed greatly reduced activity, especially toward S. Typhimurium (1/64). The low susceptibility of S. Typhimurium to polymyxin B 3 analogs with reduced hydrophobicity at positions 6 and 7 suggests that the cell membrane of this bacterium may have different characteristics from that of E. coli and P. aeruginosa. [Gly ]-polymyxin B (2-10) had the same activity in an outer membrane permeabilizing assay. 14) It is known that in the polymyxin B family of peptides, which includes colistin, D-amino acids are commonly located at position 6. However, both [L-Phe 6 ]-polymyxin B 3 (16) and [Gly 6 ]-polymyxin B 3 (12) showed considerable potency against E. coli and P. aeruginosa with MIC values of 1-2 nmol/ml. Therefore, the D-configuration at position 6 is not a prerequisite for the antimicrobial activity of polymyxin B 3 .
LPS Binding Activity The LPS binding activity of synthetic polymyxin B 3 analogs was evaluated as reported previously. 16 ) All Ala-substituted analogs for Dab residues at positions 1, 3, 5, 8 and 9 showed greatly reduced binding activity to LPS, indicating the important contribution of the Dab basic side chain to binding. On the contrary, Ala-substituted analogs for the residues at positions 2, 6, 7 and 10 had the same binding activity as polymyxin B 3 , showing a less stringent requirement for neutral side chains at these positions (Figs. 4, 5) . The positive charges of the five Dab side chains in this peptide antibiotic are believed to interact with the negative charges of the phosphate groups of LPS. 5, 6) The present results demonstrate that the g-amino function of Dab 5 makes the greatest contribution to binding to LPS by electrostatic interactions. The primary role of the amino function at position 5 was so great that the IC 50 value of [Ala 5 ]-polymyxin B 3 (4) could not be assessed under the experimental conditions of this study. The low LPS-binding activity of 4 resulted in very low antimicrobial activity, as described above. The contribution of the g-amino function of Dab 8 was the second most important contribution to binding, with an IC 50 value of 26 nmol/ml. The IC 50 values of the other Ala-substitution analogs for Dab residues at position 1, 3 and 9 were 19-20 nmol/ml.
The role of the Thr residue at position 2 appears to be more important than the Thr at position 10 for LPS binding, since the displacement curve of [Ala 2 ]-polymyxin B 3 (2) shifted to the right of that of [Ala 10 ]-polymyxin B 3 (9) . Substitution of Ala either for Phe or Leu at positions 6 and 7 did not affect binding to LPS, indicating that the slight decrease in hydrophobicity in the lactam ring was tolerated. However, the substantial loss in hydrophobicity at positions 6 and 7 resulted in a considerable decrease in binding, as seen in the displacement curve of [Gly 6 (16) towards microorganisms.
In conclusion it was found that the Dab residues located in the lactam ring of polymyxin B 3 
